MSB 1.01% $1.00 mesoblast limited

Ann: Phase 3 Trial in COVID-19 ARDS Surpasses 50% Enrollment, page-239

  1. 315 Posts.
    lightbulb Created with Sketch. 16
    What? "The results of the trial are blinded, there's no way to know anything until a result comes out," You are obviously the one touting misinformation with your claims of 'modelling'. Of course a result can be determined in a blind trial...that's the whole point!

    They have enrolled 90 ppl and analysed their outcomes at 30 days. If the preported result of 75% day 10 discharge in recepients was replicated this would be demonstrated.
    (you do realise they know that there are two cohorts right?)
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.00
Change
0.010(1.01%)
Mkt cap ! $1.141B
Open High Low Value Volume
$1.01 $1.01 94.3¢ $8.618M 8.821M

Buyers (Bids)

No. Vol. Price($)
3 43508 $1.00
 

Sellers (Offers)

Price($) Vol. No.
$1.01 34138 2
View Market Depth
Last trade - 16.10pm 01/07/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.